JPMorgan Chase ($JPM)

The SAFER Act (HR8338) is an early-stage bill referred to the House Financial Services Committee. It imposes new federal standards on custodial banks and brokerages before they can surrender customer assets to state escheatment programs. For the seven major affected firms, the net market impact is neutral to mildly positive: compliance costs increase modestly, but protecting fee-generating assets from state seizure supports retained revenue. JPMorgan Chase, Bank of America, and Morgan Stanley are the largest relative beneficiaries, while Interactive Brokers faces slightly higher proportional compliance cost. No funding is authorized, and the bill has zero near-term probability of becoming law in 2026.

HR8221, the First-Time Homebuyer Savings Act, is an early-stage bill creating a tax-advantaged savings account for first-time homebuyers with zero direct spending. Referred to the House Ways and Means Committee on April 9, 2026, with a long legislative path ahead. No near-term market impact for any publicly traded company.

HR8088 is a procedural technical correction to the inflation adjustment baseline for deposit insurance, not a coverage increase or funding authorization. At the early committee referral stage with no further action, the market impact is negligible and no publicly traded company faces a measurable revenue or cost change from this bill.

HR8087 (Main Street Depositor Protection Act) proposes raising FDIC insurance on noninterest-bearing transaction accounts to up to $5M, but remains in early procedural status with no funding mechanism. The bill reduces tail-risk of deposit flight for money-center banks but creates a contingent liability on the Deposit Insurance Fund. Real market data shows all six tracked bank stocks trading near the upper end of their 52-week ranges with positive 30-day momentum (2.89-13.55% gains), reflecting market pricing of a stable operating environment with low near-term legislative disruption risk.

S.4196 is an early-stage bill that would dramatically reduce estate and gift tax exemptions and raise top rates to 45%, but it has no near-term market impact. The bill was introduced on March 25, 2026, read twice, and referred to the Senate Finance Committee with zero subsequent action. No revenue estimates, no hearings, no CBO score, and no companion bill in the House exist. Wealth management firms, high-net-worth estate planning practices, and life insurance companies would be structurally affected only if this bill advanced — which it has not.

The Regulation A+ Improvement Act of 2026 (S.4170) triples SME capital raising limits to $150M, directly expanding fee pools for bulge-bracket investment banks ($GS, $MS, $JPM) and increasing investable product supply on retail fintech platforms ($HOOD, $SOFI, $COIN). The bill is early-stage (referred to Senate Banking Committee, no hearing yet), but related companion bill HR6541 adds cross-chamber momentum. Real market data shows GS (+8.84%), MS (+14.83%), and JPM (+6.29%) over 30 days have partially priced this expansion, while fintechs HOOD (+6.39%), SOFI (+2.71%), and COIN (+7.66%) have lagged the banks.

The Bankruptcy Threshold Adjustment Act of 2026 (S.3977 / HR7730) expands Chapter 13 consumer and small business debt eligibility 5-6x, directly increasing lender loss-given-default on unsecured credit. Pure-play Capital One ($COF at $191.14) faces the highest proportional earnings risk. The bill is on the Senate calendar with a companion House bill reported out of committee — active legislative momentum not yet reflected in bank stock rallies (+1-13% over 30 days).

HR6084, the ERISA Litigation Reform Act, has cleared the House Education & Workforce Committee on a party-line 19-13 vote and awaits floor action. The bill imposes a mandatory discovery stay during motions to dismiss and heightens pleading standards for ERISA fiduciary lawsuits, directly reducing legal costs and liability exposure for major financial institutions serving as retirement plan fiduciaries. BlackRock ($BLK), Charles Schwab ($SCHW), Morgan Stanley ($MS), JPMorgan Chase ($JPM), and Bank of America ($BAC) are the primary beneficiaries.

The Credit Union Board Modernization Act (S522) is a procedural bill that modifies board meeting frequency requirements for federally chartered credit unions. It has no direct market impact on publicly traded companies, involves no government spending, and is in early legislative stages.

The Housing Affordability Act (S.1527) proposes a 4-5x increase in FHA multifamily loan limits with construction-specific inflation indexing, creating a structural tailwind for homebuilders and multifamily lenders if passed. The bill is at early committee stage, but homebuilder stocks (DHI, MTH, LEN) have rallied 3-12% over the last 30 days reflecting sector momentum. Passage requires full committee markup, floor votes, and companion bill progress (HR6132).

The ROBINHOOD Act (HR6438) in early-stage committee referral imposes a 20% excise tax on securities-based lending for high-income borrowers, directly threatening a key wealth management revenue stream at Goldman Sachs, Morgan Stanley, and JPMorgan. Current market data shows no price impact from this bill yet — GS at $920.37 (-0.71% 7-day), MS at $188.86 (+0.42% 7-day), JPM at $312.85 (+1.48% 7-day) — as the legislative path is long. But structural risk is real: this product is a sticky, high-margin relationship anchor for wealth management franchises.

H.R. 5325 is an early-stage, bipartisan bill from September 2025 that would allow voluntary transfer of unclaimed retirement distributions to state unclaimed property programs. It creates no new revenue, spending, or liabilities — market impact is minimal to zero. The bill remains in committee with no further action in over seven months, making it legislative noise for retail investors.

HR6955 (Main Street Capital Access Act) passed out of the House Financial Services Committee on 2026-04-20 and is now on the Union Calendar. This is the most significant banking deregulation bill of the 119th Congress. It reduces capital requirements, streamlines merger reviews, modernizes the discount window, and promotes de novo bank formation. Large banks, community banks, and fintech lenders all benefit structurally. Market has already priced in initial momentum with broad banking gains over the last 30 days.

HR7205 (Application FEES Act) is a minor tax bill permitting 529 plan distributions for college application fees. The bill is in early committee stage with no meaningful market impact. Neither major 529 plan administrators like Charles Schwab nor JPMorgan Chase will see any revenue effect. The bill involves $0 in appropriations and only a narrow expansion of qualified education expenses.

HJRES10 is a proposed constitutional amendment requiring a balanced federal budget, introduced in the House and referred to committee with near-zero passage probability. It authorizes no funding and has no direct sector impact. Retail investors should ignore this bill as non-actionable noise.

The American Lending Fairness Act of 2026 (S3889) is an early-stage bill that would allow states to opt out of federal interest rate exportation preemption for loans made by their own state-chartered institutions. Introduced on February 12, 2026, and referred to the Senate Banking Committee without bill text at the time, it remains purely procedural with no market impact. The actual bill text alters a longstanding federal banking preemption rule but is not yet subject to any committee action or scheduled hearing.

HR7316 (SNAP Payment Security and Fraud Prevention Act of 2026) is an early-stage bill referred to the House Agriculture Committee. It has no specific funding authorization, no committee hearings scheduled, and no companion bill. Near-zero near-term market impact until substantive legislative action occurs.

HR507 (Veterans Member Business Loan Act) is an early-stage, zero-funding bill that would exempt veteran member business loans from credit union aggregate lending caps. No direct market impact exists. The bill is stuck at committee referral with no floor action since January 2025.

HR425, the Repealing Big Brother Overreach Act, cleared the House Financial Services Committee by a single vote (26-25) on April 21, 2026, and now awaits floor action. The bill would fully repeal the Corporate Transparency Act's beneficial ownership reporting rules, eliminating direct compliance costs for major banks like JPMorgan ($JPM), Bank of America ($BAC), and Wells Fargo ($WFC). All three stocks have rallied in the 30 days since the committee vote, and the repeal provides upside for bank earnings through reduced regulatory overhead.

HR1799, the Financial Reporting Threshold Modernization Act, raises CTR and SAR filing thresholds for the first time in decades, reducing compliance costs for banks. The bill is on the House Union Calendar after committee approval. No market-moving effect is expected — this is incremental regulatory relief, not a revenue-driven catalyst.

HR7866 is an early-stage bill that would allow states to opt out of federal interest rate preemption for loans made by banks chartered in other states. This increases the regulatory burden on large national banks like JPMorgan, Bank of America, Wells Fargo, and Citigroup by fragmenting the national lending market across potentially 50 state regimes. The bill is currently in committee with a companion bill in the Senate, but its early stage limits near-term market impact.

HR7886 (Failed Bank Executives Accountability and Consequences Act) is an early-stage bill expanding FDIC clawback authority over executive compensation for negligence causing bank losses. It increases long-term regulatory risk for all large bank holding companies but has zero near-term revenue impact. Major bank stocks showed mixed 7-day performance as of April 30, 2026, ranging from WFC +2.63% to GS -1.29%, reflecting broader market forces rather than this bill's legislative progress.

HR7887 is a single-sponsor early-stage bill referred to committee with no legislative momentum. It would prohibit stock sales by senior executives at large banks only if the bank receives a poor regulatory rating. The bill has zero market impact today. All six major bank stocks traded within normal ranges in April 2026 with no event-driven volatility tied to this legislation.

HR1340 (More Homes on the Market Act) proposes doubling the capital gains exclusion on home sales. If enacted, it would incentivize homeowners to sell, increasing housing inventory and transaction volumes. Real estate marketplace Zillow ($Z) and major mortgage lenders WFC, JPM, and BAC are structural beneficiaries.

The SSI Savings Penalty Elimination Act (HR2540) proposes to raise asset limits for 8 million low-income Americans from $2,000 to $10,000 (individuals), indexed to inflation. This creates a structural inflow of low-cost deposits to US retail banks as previously unbanked SSI recipients gain incentive to use formal banking. The bill is early-stage (referred to Ways and Means, April 2025) with 31 cosponsors — bipartisan but faces a long legislative path. Immediate market impact is low, but if enacted, major consumer banks like JPMorgan, Bank of America, and Wells Fargo would benefit from deposit growth with near-zero marginal cost.

HR6644 (21st Century ROAD to Housing Act) expands FHA multifamily loan limits and broadens HOME program eligibility, directly benefiting homebuilders (DHI, LEN, PHM, KBH, TOL) and mortgage originators (WFC, JPM, BAC, USB). The bill passed the House 50-1 and awaits Senate action. Real market data shows homebuilders with mixed 30-day trends and a recent 7-day pullback, while bank stocks rose sharply over the past week, suggesting market anticipation of housing policy tailwinds.

HR5778, the Improving SBA Engagement on Employee Ownership Act, passed the House with unanimous committee support and is now on the Union Calendar. The bill mandates the SBA to actively participate in federal employee ownership working groups and dedicate a specific program to ESOP outreach. This is a low-cost procedural win for ESOP-focused financial institutions, with no new appropriated funding but a clear structural catalyst for ESOP transaction volume. Major banks with ESOP lending and advisory operations—JPMorgan, Bank of America, and Wells Fargo—are the primary beneficiaries.

The Affordable Housing Credit Improvement Act of 2025 (S.1515) is early-stage legislation that would expand the LIHTC program, the primary federal subsidy for affordable rental housing. If enacted, it directly benefits major homebuilders with multifamily divisions ($LEN, $DHI, $PHM, $KBH, $TOL) by increasing the supply of development capital. Major bank tax equity investors ($JPM, $WFC, $BAC, $C) also benefit from expanded syndication volume.

The Neighborhood Homes Investment Act (S.1686) introduces a federal tax credit under Sec. 42A of the Internal Revenue Code to bridge the value gap in distressed-community housing construction. For homebuilders like $DHI, $PHM, and $LEN, this directly improves unit economics on affordable product. For banks like $JPM, $BAC, and $USB, it expands the addressable lending pool and creates a new tax-credit syndication revenue stream. The bill is early-stage (referred to Finance Committee), so the market is not yet pricing this catalyst.

The Merchant Banking Modernization Act (HR5291) extends the holding period for merchant banking investments from 10 to 15 years for financial holding companies. The bill is active and on the Union Calendar after passing committee with a 35-17 vote. This is a direct regulatory benefit for large banks engaged in private equity and merchant banking, particularly Goldman Sachs and Morgan Stanley, whose merchant banking divisions are core profit centers. The bill carries no direct federal spending — it is a regulatory change, not an appropriation.

The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.

The Regulation A+ Improvement Act of 2025 (HR6541) has been placed on the Union Calendar, tripling the maximum offering amount to $150 million. This expands the capital-raising capacity for small and medium enterprises, directly benefiting investment banks' equity underwriting pipelines. The bill authorizes a regulatory limit increase, not direct government spending, so market impact is structural rather than immediate budget-driven.